Weekly Digest - September 2024

Weekly Digest - September 2024

4 Sep 2024: Daiichi Sankyo showcases new breakthroughs in its leading ADC portfolio for multiple cancers at WCLC and ESMO

  • Daiichi Sankyo to present over 25 abstracts from its ADC portfolio at the 2024 WCLC and ESMO conferences
  • Six late-breaking presentations to focus on multiple cancer types, including lung, breast, gastric, ovarian, and many more
  • Highlights include datopotamab deruxtecan (Dato-DXd) data and the first clinical presentation of DS-9606, a CLDN6-directed ADC from Daiichi Sankyo’s second ADC platform
  • Key data includes results from the NeoCOAST-2 and TROPION-Lung01 lung cancer trials

For full story click here

Share this

Facebook
fb-share-icon
Twitter
Tweet
LinkedIn
Share
Home